Indonesia – January 12th, 2026 – Novo Nordisk and AstraZeneca have been named the Top 2 Best Places to Work in Indonesia for 2025 by the internationally recognized Best Places to Work certification program. This distinction highlights organizations that demonstrate excellence in workplace culture, employee engagement, and people-focused leadership.
Novo Nordisk has been awarded first place, recognized for its strong commitment to creating a purpose-driven and supportive work environment. As a global healthcare leader in diabetes care, hemophilia, and hormone therapies, Novo Nordisk combines innovation with a deeply rooted people-first philosophy. In Indonesia, the company continues to invest in employee well-being, leadership development, and inclusive practices that enable individuals to grow, perform, and make a meaningful impact. Its holistic approach to talent development and work-life integration sets a benchmark for workplace excellence.
AstraZeneca ranks second, earning recognition for its dynamic, inclusive, and high-performing organizational culture. Renowned for its scientific leadership in oncology, cardiovascular, renal, and respiratory diseases, AstraZeneca places equal focus on empowering its people. The company fosters a collaborative environment where continuous learning, flexibility, and diversity are key priorities. AstraZeneca’s commitment to innovation, employee development, and well-being continues to shape a workplace where individuals are encouraged to contribute, evolve, and succeed.
The Best Places to Work certification program evaluates organizations through comprehensive employee assessments and HR best practices, recognizing employers that consistently deliver outstanding employee experiences and cultivate sustainable workplace cultures.
For more information, visit: www.bestplacestoworkfor.org
